<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04856345</url>
  </required_header>
  <id_info>
    <org_study_id>B1152020000021</org_study_id>
    <nct_id>NCT04856345</nct_id>
  </id_info>
  <brief_title>Running Title: Walking to Music and in Silence on a Treadmill</brief_title>
  <official_title>The Effect of a 4 Week Auditory-motor Coupling Intervention on Walking, Information Processing Speed and Fatigue in Persons With Multiple Sclerosis: Three Armed Pilot Intervention</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hasselt University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Revalidatie &amp; MS Centrum Overpelt</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hasselt University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This work is embedded in the context of auditory-motor coupling, which entails the engagement&#xD;
      of two systems; the interaction between the music (or repetitive auditory stimuli) and a&#xD;
      walking individual (repetitive movements of footfall). In previous studies, the investigators&#xD;
      have shown that synchronising steps to beats in music have shown to be feasible in persons&#xD;
      with multiple sclerosis, showing increase of step frequency and reduced perceived fatigue[1,&#xD;
      2]. In this current work, The investigators expand previous findings with a pilot&#xD;
      intervention study, to investigate if synchronisation is necessary to improve cognitive and&#xD;
      motor functions.&#xD;
&#xD;
      The proposed experiment includes 30 participants, randomised to three arms of a pilot&#xD;
      intervention (10 participants per arm). With the intention of a further case-study analysis,&#xD;
      the inestigators request to include 4 additional participants (2 PwMS with cognitive&#xD;
      impairment, and 2 persons with cerebellar lesion) to only follow the intervention arm 1.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 22, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>12- item multiple sclerosis walking scale</measure>
    <time_frame>Baseline</time_frame>
    <description>The Multiple Sclerosis Walking Scale is a self-assessment scale which measures the impact of MS on walking. It consists of 12 questions concerning the limitations to walking due to MS during the past 2 weeks. Each item can be answered with 5 options, with 1 meaning no limitation and 5 extreme limitation.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>12- item multiple sclerosis walking scale</measure>
    <time_frame>week 5</time_frame>
    <description>The Multiple Sclerosis Walking Scale is a self-assessment scale which measures the impact of MS on walking. It consists of 12 questions concerning the limitations to walking due to MS during the past 2 weeks. Each item can be answered with 5 options, with 1 meaning no limitation and 5 extreme limitation.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>6 minutes walking test to calculate the distance walking Index</measure>
    <time_frame>Baseline</time_frame>
    <description>impact of MS on walking</description>
  </primary_outcome>
  <primary_outcome>
    <measure>6 minutes walking test to calculate the distance walking Index</measure>
    <time_frame>week 5</time_frame>
    <description>impact of MS on walking</description>
  </primary_outcome>
  <primary_outcome>
    <measure>12 minute walking with sensors</measure>
    <time_frame>Baseline</time_frame>
    <description>gait dynamics and pattern - detrended fluctuation analysis and spatio-temporal parameters</description>
  </primary_outcome>
  <primary_outcome>
    <measure>12 minute walking with sensors</measure>
    <time_frame>week 5</time_frame>
    <description>gait dynamics and pattern - detrended fluctuation analysis and spatio-temporal parameters</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Paced auditory serial addition test and symbol digit modality test</measure>
    <time_frame>Baseline</time_frame>
    <description>to measure cognitive functioning and cognitive fatigability</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Paced auditory serial addition test and symbol digit modality test</measure>
    <time_frame>week 5</time_frame>
    <description>to measure cognitive functioning and cognitive fatigability</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Motricity Index of dorsi flexors, knee extensors and hip flexors</measure>
    <time_frame>Baseline</time_frame>
    <description>Muscle weakness</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Motricity Index of dorsi flexors, knee extensors and hip flexors</measure>
    <time_frame>week 5</time_frame>
    <description>Muscle weakness</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Modified Aschowrth scale Hamstrings, Tricepts Surae, Quadricepts</measure>
    <time_frame>Baseline</time_frame>
    <description>Spasticity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Modified Aschowrth scale Hamstrings, Tricepts Surae, Quadricepts</measure>
    <time_frame>week 5</time_frame>
    <description>Spasticity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Scale for the assessment and rating of ataxia</measure>
    <time_frame>Baseline</time_frame>
    <description>Ataxia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Scale for the assessment and rating of ataxia</measure>
    <time_frame>week 5</time_frame>
    <description>Ataxia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dynamic gait index</measure>
    <time_frame>Baseline</time_frame>
    <description>Dynamic balance</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dynamic gait index</measure>
    <time_frame>week 5</time_frame>
    <description>Dynamic balance</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time up and Go test</measure>
    <time_frame>Baseline</time_frame>
    <description>balance</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time up and Go test</measure>
    <time_frame>week 5</time_frame>
    <description>balance</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Modified fatigue impact scale</measure>
    <time_frame>Baseline</time_frame>
    <description>self-reported outcomes for fatigue</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Modified fatigue impact scale</measure>
    <time_frame>week 5</time_frame>
    <description>self-reported outcomes for fatigue</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Barcelona music reward questionnaire</measure>
    <time_frame>Baseline</time_frame>
    <description>experience of music reward</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Barcelona music reward questionnaire</measure>
    <time_frame>week 5</time_frame>
    <description>experience of music reward</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital anxiety and depression questionnaire</measure>
    <time_frame>Baseline</time_frame>
    <description>anxiety and depression</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital anxiety and depression questionnaire</measure>
    <time_frame>week 5</time_frame>
    <description>anxiety and depression</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Activities-specific balance confidence scale</measure>
    <time_frame>Baseline</time_frame>
    <description>self-reported outcome for activity and balance</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Activities-specific balance confidence scale</measure>
    <time_frame>week 5</time_frame>
    <description>self-reported outcome for activity and balance</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stroke rehabilitation motivation scale</measure>
    <time_frame>Baseline</time_frame>
    <description>self-reported motivation questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stroke rehabilitation motivation scale</measure>
    <time_frame>week 5</time_frame>
    <description>self-reported motivation questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the Brunnel Music Rating Inventory-2</measure>
    <time_frame>Baseline</time_frame>
    <description>self-reported music rating inventory</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the Brunnel Music Rating Inventory-2</measure>
    <time_frame>week 5</time_frame>
    <description>self-reported music rating inventory</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>credibility and expectations questionnaire</measure>
    <time_frame>week 5</time_frame>
    <description>self-reporting of credibility of the intervention.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pre and Post training sessions, 2x a week, 20 minutes for 4 weeks</measure>
    <time_frame>up to week 4</time_frame>
    <description>Before and after each training session&#xD;
Perceived cognitive and physical fatigue rated on a visual analogue scale&#xD;
Perceived motivation rated on a Likert scale</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Multiple Sclerosis</condition>
  <arm_group>
    <arm_group_label>Music with synchronising</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>walking to music that one can synchronise to</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Music without synchronising</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>walking to music that one cannot synchronise to</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No music</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>walking without music.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Walking with music with synchronisation</intervention_name>
    <description>Walking with music than one can synch to</description>
    <arm_group_label>Music with synchronising</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Walking with music without synchronisation</intervention_name>
    <description>Walking with music than one cannot synch to</description>
    <arm_group_label>Music without synchronising</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>walking without music</intervention_name>
    <description>Walking without music</description>
    <arm_group_label>No music</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  A diagnosis of MS if &gt;1,&#xD;
&#xD;
          -  no relapses &gt;1 month,&#xD;
&#xD;
          -  ability to walk for 12minutes,&#xD;
&#xD;
          -  ability to walk independently on a treadmill&#xD;
&#xD;
          -  walking speed between 0.8-1.2m/s.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  amusia,&#xD;
&#xD;
          -  deafness,&#xD;
&#xD;
          -  cognitive impairment hindering understanding of study instructions,&#xD;
&#xD;
          -  pregnancy.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter Feyse, prof. dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hasselt University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lousin Moumdjian, dr.</last_name>
    <role>Study Chair</role>
    <affiliation>Hasselt University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Peter Feys, prof. dr.</last_name>
    <phone>+32 11 29 21 23</phone>
    <email>peter.feys@uhasselt.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lousin moumdjian, dr.</last_name>
    <phone>+32 11 26 93 71</phone>
    <email>lousin.moumdjian@uhasselt.be</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Noorderhart Revalidatie &amp; MS centrum</name>
      <address>
        <city>Overpelt</city>
        <zip>3900</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lousin moumdjian, dr.</last_name>
      <phone>+32 11 26 9371</phone>
      <email>lousine.moumdjian@uhasselt.be</email>
    </contact>
    <contact_backup>
      <last_name>Ilse Lamers, dr.</last_name>
      <phone>+3211 28 69 39</phone>
      <email>ilse.lamers@uhasselt.be</email>
    </contact_backup>
    <investigator>
      <last_name>Ilse Bosmans</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>February 2, 2021</study_first_submitted>
  <study_first_submitted_qc>April 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 23, 2021</study_first_posted>
  <last_update_submitted>April 19, 2021</last_update_submitted>
  <last_update_submitted_qc>April 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hasselt University</investigator_affiliation>
    <investigator_full_name>Peter Feys</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Multiple Sclerosis</mesh_term>
    <mesh_term>Sclerosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

